These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29103425)

  • 1. Cancer and Autoimmunity: Paraneoplastic Neurological Disorders Associated With Neuroblastic Tumors.
    Mitchell WG; Blaes F
    Semin Pediatr Neurol; 2017 Aug; 24(3):180-188. PubMed ID: 29103425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
    Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
    Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.
    Pranzatelli MR; Tate ED; McGee NR
    Front Neurol; 2017; 8():468. PubMed ID: 28959231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
    Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
    Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic neurological syndrome in 12 children].
    Xiao J; Liu LY; Wu Y; Han TL; Wang X
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):598-600. PubMed ID: 23158737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.
    Fukushima H; Inoue T; Takama Y; Ishii N; Okuno T; Kobayashi Y; Yoneda A; Nakamura T; Kuki I; Hara J
    Pathol Int; 2017 Oct; 67(10):503-509. PubMed ID: 28971571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
    Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
    Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on pediatric opsoclonus myoclonus syndrome.
    Hero B; Schleiermacher G
    Neuropediatrics; 2013 Dec; 44(6):324-9. PubMed ID: 24203854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
    Bell J; Moran C; Blatt J
    Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and Histological Variations of Neuroblastoma and Ganglioneuroblastoma with Paraneoplastic Syndromes.
    Mina AS; Nashed GN; Hermina AM; Schauwecker SM; Phelps HM; Benedetti DJ; Correa H; Lovvorn HN
    Am Surg; 2023 Sep; 89(9):3745-3750. PubMed ID: 37150742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Whole-body magnetic resonance imaging in a patient with an occult abdominal neuroblastoma and opsoclonus-myoclonus syndrome].
    Miras Azcón F; Culiañez Casas M; Pastor Pons E
    Radiologia; 2014; 56(6):e54-7. PubMed ID: 22818898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic opsoclonus-myoclonus syndrome (POMS)].
    Matsumoto H; Ugawa Y
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():763-7. PubMed ID: 26480791
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
    Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity.
    Raffaghello L; Fuhlhuber V; Bianchi G; Conte M; Blaes F; Gambini C; Pistoia V
    J Leukoc Biol; 2013 Jul; 94(1):183-91. PubMed ID: 23610147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.